Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358670
Status:
TERMINATED
Last Update Posted:
2017-04-11
First Post:
2006-07-31
Brief Title:
Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis Extension of Study P04271 NCT00251641 P04563
Sponsor:
Organization:
Merck Sharp Dohme LLC